Hindcon Chemicals（HINDCON）株式概要ヒンドコン・ケミカルズ社は、ケイ酸ナトリウムと建設用化学品の製造・販売、および関連サービスをインド国内外で行っている。 詳細HINDCON ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性4/6配当金0/6リスク分析高いレベルの非現金収入 過去5年間で収益は年間2.5%減少しました。 意味のある時価総額がありません ( ₹1B )Indian市場と比較した過去 3 か月間の株価の変動すべてのリスクチェックを見るHINDCON Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹21.0765.1% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture0856m2016201920222025202620282031Revenue ₹636.0mEarnings ₹31.6mAdvancedSet Fair ValueView all narrativesHindcon Chemicals Limited 競合他社Paragon Fine And Speciality ChemicalSymbol: NSEI:PARAGONMarket cap: ₹984.2mBiopol ChemicalsSymbol: NSEI:BIOPOLMarket cap: ₹1.0bPolsonSymbol: BSE:507645Market cap: ₹1.4bCochin Minerals and RutileSymbol: BSE:513353Market cap: ₹2.0b価格と性能株価の高値、安値、推移の概要Hindcon Chemicals過去の株価現在の株価₹21.0752週高値₹37.7552週安値₹15.66ベータ0.00211ヶ月の変化-5.30%3ヶ月変化11.36%1年変化-39.03%3年間の変化12.01%5年間の変化179.07%IPOからの変化259.56%最新ニュースReported Earnings • May 17Full year 2026 earnings released: EPS: ₹0.84 (vs ₹0.99 in FY 2025)Full year 2026 results: EPS: ₹0.84 (down from ₹0.99 in FY 2025). Revenue: ₹672.6m (up 19% from FY 2025). Net income: ₹32.3m (down 15% from FY 2025). Profit margin: 4.8% (down from 6.7% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.お知らせ • May 08Hindcon Chemicals Limited to Report Q4, 2026 Results on May 14, 2026Hindcon Chemicals Limited announced that they will report Q4, 2026 results on May 14, 2026New Risk • Apr 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.9% net profit margin). Market cap is less than US$100m (₹1.19b market cap, or US$12.8m).Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹19.31, the stock trades at a trailing P/E ratio of 33.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 18% over the past three years.New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹936.3m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.7% per year over the past 5 years. Market cap is less than US$10m (₹936.3m market cap, or US$9.99m). Minor Risk Profit margins are more than 30% lower than last year (4.9% net profit margin).New Risk • Feb 04New major risk - Revenue and earnings growthEarnings have declined by 0.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.9% net profit margin). Market cap is less than US$100m (₹1.17b market cap, or US$12.9m).最新情報をもっと見るRecent updatesReported Earnings • May 17Full year 2026 earnings released: EPS: ₹0.84 (vs ₹0.99 in FY 2025)Full year 2026 results: EPS: ₹0.84 (down from ₹0.99 in FY 2025). Revenue: ₹672.6m (up 19% from FY 2025). Net income: ₹32.3m (down 15% from FY 2025). Profit margin: 4.8% (down from 6.7% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.お知らせ • May 08Hindcon Chemicals Limited to Report Q4, 2026 Results on May 14, 2026Hindcon Chemicals Limited announced that they will report Q4, 2026 results on May 14, 2026New Risk • Apr 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.9% net profit margin). Market cap is less than US$100m (₹1.19b market cap, or US$12.8m).Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹19.31, the stock trades at a trailing P/E ratio of 33.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 18% over the past three years.New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹936.3m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.7% per year over the past 5 years. Market cap is less than US$10m (₹936.3m market cap, or US$9.99m). Minor Risk Profit margins are more than 30% lower than last year (4.9% net profit margin).New Risk • Feb 04New major risk - Revenue and earnings growthEarnings have declined by 0.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.9% net profit margin). Market cap is less than US$100m (₹1.17b market cap, or US$12.9m).Reported Earnings • Feb 04Third quarter 2026 earnings released: EPS: ₹0.08 (vs ₹0.35 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.08 (down from ₹0.35 in 3Q 2025). Revenue: ₹142.3m (down 6.8% from 3Q 2025). Net income: ₹3.23m (down 76% from 3Q 2025). Profit margin: 2.3% (down from 8.9% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.分析記事 • Jan 22Hindcon Chemicals Limited's (NSE:HINDCON) 27% Share Price Plunge Could Signal Some RiskUnfortunately for some shareholders, the Hindcon Chemicals Limited ( NSE:HINDCON ) share price has dived 27% in the...Valuation Update With 7 Day Price Move • Jan 21Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹20.21, the stock trades at a trailing P/E ratio of 25.9x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 12% over the past three years.分析記事 • Sep 17Shareholders May Be More Conservative With Hindcon Chemicals Limited's (NSE:HINDCON) CEO Compensation For NowKey Insights Hindcon Chemicals will host its Annual General Meeting on 23rd of September CEO Sanjay Goenka's total...New Risk • Aug 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹1.72b market cap, or US$19.6m).お知らせ • Aug 11Hindcon Chemicals Limited, Annual General Meeting, Sep 23, 2025Hindcon Chemicals Limited, Annual General Meeting, Sep 23, 2025.Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹37.73, the stock trades at a trailing P/E ratio of 38.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 173% over the past three years.Valuation Update With 7 Day Price Move • Mar 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹30.79, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.分析記事 • Mar 05Hindcon Chemicals Limited's (NSE:HINDCON) Shares May Have Run Too Fast Too SoonWhen close to half the companies in India have price-to-earnings ratios (or "P/E's") below 24x, you may consider...Reported Earnings • Jan 30Third quarter 2025 earnings released: EPS: ₹0.35 (vs ₹0.26 in 3Q 2024)Third quarter 2025 results: EPS: ₹0.35 (up from ₹0.26 in 3Q 2024). Revenue: ₹161.3m (up 20% from 3Q 2024). Net income: ₹13.6m (up 37% from 3Q 2024). Profit margin: 8.5% (up from 7.4% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 43% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 33% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹2.14b market cap, or US$24.7m).New Risk • Nov 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.6% average weekly change). Shareholders have been diluted in the past year (33% increase in shares outstanding). Market cap is less than US$100m (₹2.47b market cap, or US$29.2m).Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹48.20, the stock trades at a trailing P/E ratio of 52.8x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 328% over the past three years.分析記事 • Nov 02There's Reason For Concern Over Hindcon Chemicals Limited's (NSE:HINDCON) PriceWith a price-to-earnings (or "P/E") ratio of 49.3x Hindcon Chemicals Limited ( NSE:HINDCON ) may be sending very...Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹56.46, the stock trades at a trailing P/E ratio of 58.3x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 348% over the past three years.分析記事 • Aug 14Shareholders May Be More Conservative With Hindcon Chemicals Limited's (NSE:HINDCON) CEO Compensation For NowKey Insights Hindcon Chemicals to hold its Annual General Meeting on 20th of August CEO Sanjay Goenka's total...Reported Earnings • Aug 10First quarter 2025 earnings released: EPS: ₹0.34 (vs ₹0.66 in 1Q 2024)First quarter 2025 results: EPS: ₹0.34 (down from ₹0.66 in 1Q 2024). Revenue: ₹132.7m (down 23% from 1Q 2024). Net income: ₹13.0m (down 48% from 1Q 2024). Profit margin: 9.8% (down from 15% in 1Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • Aug 06Upcoming dividend of ₹0.10 per shareEligible shareholders must have bought the stock before 13 August 2024. Payment date: 19 September 2024. Payout ratio is a comfortable 12% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).New Risk • Aug 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 33% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (33% increase in shares outstanding). Market cap is less than US$100m (₹2.86b market cap, or US$34.1m).お知らせ • Jul 16Hindcon Chemicals Limited, Annual General Meeting, Aug 20, 2024Hindcon Chemicals Limited, Annual General Meeting, Aug 20, 2024.Recent Insider Transactions • Jun 22Chairman & MD recently bought ₹2.0m worth of stockOn the 19th of June, Sanjay Goenka bought around 40k shares on-market at roughly ₹49.42 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹5.2m worth in shares.Buy Or Sell Opportunity • May 19Now 21% overvaluedOver the last 90 days, the stock has fallen 15% to ₹53.25. The fair value is estimated to be ₹43.96, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 9.4%.Board Change • May 07Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. Independent Director Divyaa Newatia was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • May 02Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹59.10, the stock trades at a trailing P/E ratio of 39.5x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 1,043% over the past three years.Buy Or Sell Opportunity • Apr 03Now 20% overvaluedOver the last 90 days, the stock has fallen 4.4% to ₹53.25. The fair value is estimated to be ₹44.36, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 9.4%.Valuation Update With 7 Day Price Move • Mar 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹52.05, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 1,020% over the past three years.分析記事 • Mar 21Risks Still Elevated At These Prices As Hindcon Chemicals Limited (NSE:HINDCON) Shares Dive 26%Hindcon Chemicals Limited ( NSE:HINDCON ) shares have had a horrible month, losing 26% after a relatively good period...Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹59.70, the stock trades at a trailing P/E ratio of 39.9x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 1,211% over the past three years.分析記事 • Feb 15With EPS Growth And More, Hindcon Chemicals (NSE:HINDCON) Makes An Interesting CaseInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Buy Or Sell Opportunity • Feb 01Now 19% overvalued after recent price riseOver the last 90 days, the stock has risen 85% to ₹49.65. The fair value is estimated to be ₹41.79, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 9.4%.Reported Earnings • Feb 01Third quarter 2024 earnings released: EPS: ₹0.26 (vs ₹0.37 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.26 (down from ₹0.37 in 3Q 2023). Revenue: ₹134.4m (down 50% from 3Q 2023). Net income: ₹9.99m (down 29% from 3Q 2023). Profit margin: 7.4% (up from 5.3% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Dec 20Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₹49.05, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 932% over the past three years.分析記事 • Dec 19What Hindcon Chemicals Limited's (NSE:HINDCON) 31% Share Price Gain Is Not Telling YouHindcon Chemicals Limited ( NSE:HINDCON ) shares have continued their recent momentum with a 31% gain in the last month...分析記事 • Nov 11Is Now The Time To Put Hindcon Chemicals (NSE:HINDCON) On Your Watchlist?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Recent Insider Transactions • Sep 03Whole Time Director recently bought ₹2.0m worth of stockOn the 29th of August, Nilima Goenka bought around 14k shares on-market at roughly ₹144 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹3.4m more in shares than they have sold in the last 12 months.Reported Earnings • Aug 14First quarter 2024 earnings released: EPS: ₹3.32 (vs ₹1.35 in 1Q 2023)First quarter 2024 results: EPS: ₹3.32 (up from ₹1.35 in 1Q 2023). Revenue: ₹176.9m (down 16% from 1Q 2023). Net income: ₹25.3m (up 147% from 1Q 2023). Profit margin: 14% (up from 4.9% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 95% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 13Hindcon Chemicals Limited to Report Q1, 2024 Results on Aug 12, 2023Hindcon Chemicals Limited announced that they will report Q1, 2024 results on Aug 12, 2023New Risk • Aug 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.4% average weekly change). Market cap is less than US$100m (₹1.03b market cap, or US$12.4m).Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹112, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 633% over the past three years.お知らせ • Aug 03Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2023Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2023, at 14:00 Indian Standard Time. Location: Hindusthan Club Limited, 4/1, Sarat Bose Road, 2nd Floor Kolkata-700 020 Kolkata India Agenda: To receive, consider and adopt the Standalone and Consolidated Financial Statement of the Company including Audited Balance Sheet as at 31 March, 2023, Audited Statement of Profit and Loss and the Cash Flow Statement for the year ended as on that date together with Report of Directors' and Auditors' thereon; to appoint a Director in place of Mr. Ramsanatan Banerjee, retiring by rotation and being eligible, offered himself for re-appointment; and to consider other business matters.Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹94.55, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 939% over the past three years.Recent Insider Transactions • Mar 27Whole Time Director recently bought ₹63k worth of stockOn the 24th of March, Nilima Goenka bought around 786 shares on-market at roughly ₹79.63 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹450k more in shares than they have sold in the last 12 months.Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: ₹1.84 (vs ₹1.39 in 3Q 2022)Third quarter 2023 results: EPS: ₹1.84 (up from ₹1.39 in 3Q 2022). Revenue: ₹266.4m (up 60% from 3Q 2022). Net income: ₹14.0m (up 32% from 3Q 2022). Profit margin: 5.3% (down from 6.4% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 97% per year, which means it is tracking significantly ahead of earnings growth.Recent Insider Transactions • Dec 27Chairman & MD recently bought ₹263k worth of stockOn the 22nd of December, Sanjay Goenka bought around 3k shares on-market at roughly ₹87.57 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Sanjay's only on-market trade for the last 12 months.Reported Earnings • Nov 20Second quarter 2023 earnings released: EPS: ₹0.71 (vs ₹0.97 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.71 (down from ₹0.97 in 2Q 2022). Revenue: ₹190.5m (up 25% from 2Q 2022). Net income: ₹5.41m (down 27% from 2Q 2022). Profit margin: 2.8% (down from 4.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 85% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Oct 13Investor sentiment improved over the past weekAfter last week's 46% share price gain to ₹126, the stock trades at a trailing P/E ratio of 32x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 703% over the past three years.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹76.80, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 391% over the past three years.Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹87.40, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 462% over the past three years.Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹73.45, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 372% over the past three years.Upcoming Dividend • Aug 11Upcoming dividend of ₹0.70 per shareEligible shareholders must have bought the stock before 18 August 2022. Payment date: 25 September 2022. Payout ratio is a comfortable 31% but the company is not cash flow positive. Trailing yield: 2.2%. Within top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (0.7%).お知らせ • Aug 06Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2022Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2022, at 13:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₹49.65, the stock trades at a trailing P/E ratio of 12x. Average trailing P/E is 16x in the Chemicals industry in India. Total returns to shareholders of 180% over the past three years.Reported Earnings • May 31Full year 2022 earnings releasedFull year 2022 results: Revenue: ₹679.9m (up 53% from FY 2021). Net income: ₹42.3m (down 6.4% from FY 2021). Profit margin: 6.2% (down from 10% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Girdhari Goenka was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Mar 11Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹75.50, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 354% over the past three years.Reported Earnings • Feb 15Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.39 (down from ₹1.61 in 3Q 2021). Revenue: ₹169.9m (up 31% from 3Q 2021). Net income: ₹10.6m (down 14% from 3Q 2021). Profit margin: 6.3% (down from 9.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹70.20, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 305% over the past three years.Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹70.20, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 305% over the past three years.Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS ₹0.97 (vs ₹1.48 in 2Q 2021)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹155.8m (up 48% from 2Q 2021). Net income: ₹7.41m (down 34% from 2Q 2021). Profit margin: 4.8% (down from 11% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 20First quarter 2021 earnings released: EPS ₹1.47 (vs ₹0.72 in 1Q 2020)The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: ₹77.0m (down 25% from 1Q 2020). Net income: ₹11.3m (up 104% from 1Q 2020). Profit margin: 15% (up from 5.4% in 1Q 2020). The increase in margin was driven by lower expenses.Upcoming Dividend • Aug 19Upcoming dividend of ₹2.50 per shareEligible shareholders must have bought the stock before 26 August 2021. Payment date: 13 September 2021. Trailing yield: 2.3%. Within top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.7%).分析記事 • Aug 14Hindcon Chemicals (NSE:HINDCON) Is Increasing Its Dividend To ₹1.50The board of Hindcon Chemicals Limited ( NSE:HINDCON ) has announced that it will be increasing its dividend on the 4th...Valuation Update With 7 Day Price Move • Jul 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹41.75, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 105% over the past three years.Recent Insider Transactions • Jul 02Whole Time Director recently bought ₹743k worth of stockOn the 29th of June, Nilima Goenka bought around 20k shares on-market at roughly ₹37.17 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹2.6m more in shares than they have sold in the last 12 months.Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹32.55, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 30% over the past three years.Valuation Update With 7 Day Price Move • May 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹25.80, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 14% over the past three years.分析記事 • May 03Is Hindcon Chemicals Limited (NSE:HINDCON) An Attractive Dividend Stock?Is Hindcon Chemicals Limited ( NSE:HINDCON ) a good dividend stock? How can we tell? Dividend paying companies with...Valuation Update With 7 Day Price Move • Feb 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹20.25, the stock is trading at a trailing P/E ratio of 5.5x, down from the previous P/E ratio of 6.5x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past year are 76%.分析記事 • Feb 20Estimating The Fair Value Of Hindcon Chemicals Limited (NSE:HINDCON)Does the February share price for Hindcon Chemicals Limited ( NSE:HINDCON ) reflect what it's really worth? Today, we...Is New 90 Day High Low • Feb 18New 90-day low: ₹24.00The company is down 4.0% from its price of ₹25.00 on 20 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.Recent Insider Transactions • Jan 30MD & Director recently bought ₹100k worth of stockOn the 27th of January, Sanjay Goenka bought around 4k shares on-market at roughly ₹25.08 per share. In the last 3 months, they made an even bigger purchase worth ₹209k. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹2.6m worth in shares.分析記事 • Jan 16Should Hindcon Chemicals Limited (NSE:HINDCON) Be Part Of Your Dividend Portfolio?Dividend paying stocks like Hindcon Chemicals Limited ( NSE:HINDCON ) tend to be popular with investors, and for good...Recent Insider Transactions • Jan 16MD & Director recently bought ₹201k worth of stockOn the 13th of January, Sanjay Goenka bought around 8k shares on-market at roughly ₹25.18 per share. In the last 3 months, they made an even bigger purchase worth ₹209k. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹2.5m worth in shares.Recent Insider Transactions • Jan 06MD & Director recently bought ₹305k worth of stockOn the 29th of December, Sanjay Goenka bought around 12k shares on-market at roughly ₹25.41 per share. This was the largest purchase by an insider in the last 3 months. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹2.6m worth in shares.分析記事 • Dec 21Whole Time Director Nilima Goenka Just Bought 1.1% More Shares In Hindcon Chemicals Limited (NSE:HINDCON)Whilst it may not be a huge deal, we thought it was good to see that the Hindcon Chemicals Limited ( NSE:HINDCON...分析記事 • Dec 07Trade Alert: The MD & Director Of Hindcon Chemicals Limited (NSE:HINDCON), Sanjay Goenka, Has Just Spent ₹209k Buying A Few More SharesEven if it's not a huge purchase, we think it was good to see that Sanjay Goenka, the MD & Director of Hindcon...Recent Insider Transactions • Dec 07MD & Director recently bought ₹209k worth of stockOn the 4th of December, Sanjay Goenka bought around 8k shares on-market at roughly ₹26.18 per share. This was the largest purchase by an insider in the last 3 months. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹2.1m worth in shares.分析記事 • Nov 19Read This Before Selling Hindcon Chemicals Limited (NSE:HINDCON) SharesWe often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...Valuation Update With 7 Day Price Move • Nov 18Market bids up stock over the past weekAfter last week's 15% share price gain to ₹22.45, the stock is trading at a trailing P/E ratio of 6.1x, up from the previous P/E ratio of 5.3x. This compares to an average P/E of 16x in the Chemicals industry in India.Is New 90 Day High Low • Nov 15New 90-day high: ₹19.70The company is up 11% from its price of ₹17.80 on 17 August 2020. The Indian market is also up 11% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 13% over the same period.Recent Insider Transactions • Oct 03Whole Time Director recently bought ₹660k worth of stockOn the 30th of September, Nilima Goenka bought around 36k shares on-market at roughly ₹18.34 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.4m. Insiders have collectively bought ₹2.5m more in shares than they have sold in the last 12 months.お知らせ • Jul 17+ 1 more updateHindcon Chemicals Limited to Report First Half, 2020 Results on Jun 25, 2020Hindcon Chemicals Limited announced that they will report first half, 2020 results on Jun 25, 2020株主還元HINDCONIN ChemicalsIN 市場7D-2.1%1.8%2.1%1Y-39.0%-0.8%1.5%株主還元を見る業界別リターン: HINDCON過去 1 年間で-0.8 % の収益を上げたIndian Chemicals業界を下回りました。リターン対市場: HINDCONは、過去 1 年間で1.5 % のリターンを上げたIndian市場を下回りました。価格変動Is HINDCON's price volatile compared to industry and market?HINDCON volatilityHINDCON Average Weekly Movement8.7%Chemicals Industry Average Movement7.2%Market Average Movement7.1%10% most volatile stocks in IN Market10.2%10% least volatile stocks in IN Market4.6%安定した株価: HINDCONの株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: HINDCONの weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1947124Sanjay Goenkawww.hindcon.comヒンドコン・ケミカルズ社は、ケイ酸ナトリウムと建設用化学品の製造・販売、および関連サービスをインド国内外で行っている。セメント添加剤製品を提供しており、その中にはコーティングと含浸、コンクリートとモルタル混和剤、エポキシグラウトとモルタル、伸縮継手システム、床材、鋳造補助剤、建築プロジェクト用グリーン製品、グラウト、保護コーティングとシート、除去剤と洗浄剤、シーラント、ショットクライト補助剤、タイル接着剤、防水コンパウンド、コンクリートと研削補助剤、掘削補助剤が含まれる。また、防水・補修、改修・再構築、仕様サービスなど様々なサービスも提供している。以前はHind Silicates Pvt Ltd.として知られていた。ヒンドコン・ケミカルズ社は1947年に設立され、インドのコルカタに本拠を置く。もっと見るHindcon Chemicals Limited 基礎のまとめHindcon Chemicals の収益と売上を時価総額と比較するとどうか。HINDCON 基礎統計学時価総額₹1.08b収益（TTM）₹32.33m売上高(TTM)₹650.21m33.4xPER（株価収益率1.7xP/SレシオHINDCON は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計HINDCON 損益計算書（TTM）収益₹650.21m売上原価₹472.07m売上総利益₹178.13mその他の費用₹145.80m収益₹32.33m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）0.63グロス・マージン27.40%純利益率4.97%有利子負債／自己資本比率18.6%HINDCON の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/23 18:17終値2026/06/23 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Hindcon Chemicals Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 17Full year 2026 earnings released: EPS: ₹0.84 (vs ₹0.99 in FY 2025)Full year 2026 results: EPS: ₹0.84 (down from ₹0.99 in FY 2025). Revenue: ₹672.6m (up 19% from FY 2025). Net income: ₹32.3m (down 15% from FY 2025). Profit margin: 4.8% (down from 6.7% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
お知らせ • May 08Hindcon Chemicals Limited to Report Q4, 2026 Results on May 14, 2026Hindcon Chemicals Limited announced that they will report Q4, 2026 results on May 14, 2026
New Risk • Apr 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.9% net profit margin). Market cap is less than US$100m (₹1.19b market cap, or US$12.8m).
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹19.31, the stock trades at a trailing P/E ratio of 33.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 18% over the past three years.
New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹936.3m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.7% per year over the past 5 years. Market cap is less than US$10m (₹936.3m market cap, or US$9.99m). Minor Risk Profit margins are more than 30% lower than last year (4.9% net profit margin).
New Risk • Feb 04New major risk - Revenue and earnings growthEarnings have declined by 0.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.9% net profit margin). Market cap is less than US$100m (₹1.17b market cap, or US$12.9m).
Reported Earnings • May 17Full year 2026 earnings released: EPS: ₹0.84 (vs ₹0.99 in FY 2025)Full year 2026 results: EPS: ₹0.84 (down from ₹0.99 in FY 2025). Revenue: ₹672.6m (up 19% from FY 2025). Net income: ₹32.3m (down 15% from FY 2025). Profit margin: 4.8% (down from 6.7% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
お知らせ • May 08Hindcon Chemicals Limited to Report Q4, 2026 Results on May 14, 2026Hindcon Chemicals Limited announced that they will report Q4, 2026 results on May 14, 2026
New Risk • Apr 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.9% net profit margin). Market cap is less than US$100m (₹1.19b market cap, or US$12.8m).
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹19.31, the stock trades at a trailing P/E ratio of 33.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 18% over the past three years.
New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹936.3m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.7% per year over the past 5 years. Market cap is less than US$10m (₹936.3m market cap, or US$9.99m). Minor Risk Profit margins are more than 30% lower than last year (4.9% net profit margin).
New Risk • Feb 04New major risk - Revenue and earnings growthEarnings have declined by 0.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 0.7% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (4.9% net profit margin). Market cap is less than US$100m (₹1.17b market cap, or US$12.9m).
Reported Earnings • Feb 04Third quarter 2026 earnings released: EPS: ₹0.08 (vs ₹0.35 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.08 (down from ₹0.35 in 3Q 2025). Revenue: ₹142.3m (down 6.8% from 3Q 2025). Net income: ₹3.23m (down 76% from 3Q 2025). Profit margin: 2.3% (down from 8.9% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
分析記事 • Jan 22Hindcon Chemicals Limited's (NSE:HINDCON) 27% Share Price Plunge Could Signal Some RiskUnfortunately for some shareholders, the Hindcon Chemicals Limited ( NSE:HINDCON ) share price has dived 27% in the...
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹20.21, the stock trades at a trailing P/E ratio of 25.9x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 12% over the past three years.
分析記事 • Sep 17Shareholders May Be More Conservative With Hindcon Chemicals Limited's (NSE:HINDCON) CEO Compensation For NowKey Insights Hindcon Chemicals will host its Annual General Meeting on 23rd of September CEO Sanjay Goenka's total...
New Risk • Aug 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹1.72b market cap, or US$19.6m).
お知らせ • Aug 11Hindcon Chemicals Limited, Annual General Meeting, Sep 23, 2025Hindcon Chemicals Limited, Annual General Meeting, Sep 23, 2025.
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹37.73, the stock trades at a trailing P/E ratio of 38.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 173% over the past three years.
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹30.79, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.
分析記事 • Mar 05Hindcon Chemicals Limited's (NSE:HINDCON) Shares May Have Run Too Fast Too SoonWhen close to half the companies in India have price-to-earnings ratios (or "P/E's") below 24x, you may consider...
Reported Earnings • Jan 30Third quarter 2025 earnings released: EPS: ₹0.35 (vs ₹0.26 in 3Q 2024)Third quarter 2025 results: EPS: ₹0.35 (up from ₹0.26 in 3Q 2024). Revenue: ₹161.3m (up 20% from 3Q 2024). Net income: ₹13.6m (up 37% from 3Q 2024). Profit margin: 8.5% (up from 7.4% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 43% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 33% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹2.14b market cap, or US$24.7m).
New Risk • Nov 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.6% average weekly change). Shareholders have been diluted in the past year (33% increase in shares outstanding). Market cap is less than US$100m (₹2.47b market cap, or US$29.2m).
Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹48.20, the stock trades at a trailing P/E ratio of 52.8x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 328% over the past three years.
分析記事 • Nov 02There's Reason For Concern Over Hindcon Chemicals Limited's (NSE:HINDCON) PriceWith a price-to-earnings (or "P/E") ratio of 49.3x Hindcon Chemicals Limited ( NSE:HINDCON ) may be sending very...
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹56.46, the stock trades at a trailing P/E ratio of 58.3x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 348% over the past three years.
分析記事 • Aug 14Shareholders May Be More Conservative With Hindcon Chemicals Limited's (NSE:HINDCON) CEO Compensation For NowKey Insights Hindcon Chemicals to hold its Annual General Meeting on 20th of August CEO Sanjay Goenka's total...
Reported Earnings • Aug 10First quarter 2025 earnings released: EPS: ₹0.34 (vs ₹0.66 in 1Q 2024)First quarter 2025 results: EPS: ₹0.34 (down from ₹0.66 in 1Q 2024). Revenue: ₹132.7m (down 23% from 1Q 2024). Net income: ₹13.0m (down 48% from 1Q 2024). Profit margin: 9.8% (down from 15% in 1Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • Aug 06Upcoming dividend of ₹0.10 per shareEligible shareholders must have bought the stock before 13 August 2024. Payment date: 19 September 2024. Payout ratio is a comfortable 12% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).
New Risk • Aug 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 33% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (33% increase in shares outstanding). Market cap is less than US$100m (₹2.86b market cap, or US$34.1m).
お知らせ • Jul 16Hindcon Chemicals Limited, Annual General Meeting, Aug 20, 2024Hindcon Chemicals Limited, Annual General Meeting, Aug 20, 2024.
Recent Insider Transactions • Jun 22Chairman & MD recently bought ₹2.0m worth of stockOn the 19th of June, Sanjay Goenka bought around 40k shares on-market at roughly ₹49.42 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹5.2m worth in shares.
Buy Or Sell Opportunity • May 19Now 21% overvaluedOver the last 90 days, the stock has fallen 15% to ₹53.25. The fair value is estimated to be ₹43.96, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 9.4%.
Board Change • May 07Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. Independent Director Divyaa Newatia was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • May 02Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹59.10, the stock trades at a trailing P/E ratio of 39.5x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 1,043% over the past three years.
Buy Or Sell Opportunity • Apr 03Now 20% overvaluedOver the last 90 days, the stock has fallen 4.4% to ₹53.25. The fair value is estimated to be ₹44.36, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 9.4%.
Valuation Update With 7 Day Price Move • Mar 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹52.05, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 1,020% over the past three years.
分析記事 • Mar 21Risks Still Elevated At These Prices As Hindcon Chemicals Limited (NSE:HINDCON) Shares Dive 26%Hindcon Chemicals Limited ( NSE:HINDCON ) shares have had a horrible month, losing 26% after a relatively good period...
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹59.70, the stock trades at a trailing P/E ratio of 39.9x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 1,211% over the past three years.
分析記事 • Feb 15With EPS Growth And More, Hindcon Chemicals (NSE:HINDCON) Makes An Interesting CaseInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Buy Or Sell Opportunity • Feb 01Now 19% overvalued after recent price riseOver the last 90 days, the stock has risen 85% to ₹49.65. The fair value is estimated to be ₹41.79, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 9.4%.
Reported Earnings • Feb 01Third quarter 2024 earnings released: EPS: ₹0.26 (vs ₹0.37 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.26 (down from ₹0.37 in 3Q 2023). Revenue: ₹134.4m (down 50% from 3Q 2023). Net income: ₹9.99m (down 29% from 3Q 2023). Profit margin: 7.4% (up from 5.3% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Dec 20Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₹49.05, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 932% over the past three years.
分析記事 • Dec 19What Hindcon Chemicals Limited's (NSE:HINDCON) 31% Share Price Gain Is Not Telling YouHindcon Chemicals Limited ( NSE:HINDCON ) shares have continued their recent momentum with a 31% gain in the last month...
分析記事 • Nov 11Is Now The Time To Put Hindcon Chemicals (NSE:HINDCON) On Your Watchlist?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Recent Insider Transactions • Sep 03Whole Time Director recently bought ₹2.0m worth of stockOn the 29th of August, Nilima Goenka bought around 14k shares on-market at roughly ₹144 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹3.4m more in shares than they have sold in the last 12 months.
Reported Earnings • Aug 14First quarter 2024 earnings released: EPS: ₹3.32 (vs ₹1.35 in 1Q 2023)First quarter 2024 results: EPS: ₹3.32 (up from ₹1.35 in 1Q 2023). Revenue: ₹176.9m (down 16% from 1Q 2023). Net income: ₹25.3m (up 147% from 1Q 2023). Profit margin: 14% (up from 4.9% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 95% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 13Hindcon Chemicals Limited to Report Q1, 2024 Results on Aug 12, 2023Hindcon Chemicals Limited announced that they will report Q1, 2024 results on Aug 12, 2023
New Risk • Aug 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.4% average weekly change). Market cap is less than US$100m (₹1.03b market cap, or US$12.4m).
Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹112, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 633% over the past three years.
お知らせ • Aug 03Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2023Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2023, at 14:00 Indian Standard Time. Location: Hindusthan Club Limited, 4/1, Sarat Bose Road, 2nd Floor Kolkata-700 020 Kolkata India Agenda: To receive, consider and adopt the Standalone and Consolidated Financial Statement of the Company including Audited Balance Sheet as at 31 March, 2023, Audited Statement of Profit and Loss and the Cash Flow Statement for the year ended as on that date together with Report of Directors' and Auditors' thereon; to appoint a Director in place of Mr. Ramsanatan Banerjee, retiring by rotation and being eligible, offered himself for re-appointment; and to consider other business matters.
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹94.55, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 939% over the past three years.
Recent Insider Transactions • Mar 27Whole Time Director recently bought ₹63k worth of stockOn the 24th of March, Nilima Goenka bought around 786 shares on-market at roughly ₹79.63 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹450k more in shares than they have sold in the last 12 months.
Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: ₹1.84 (vs ₹1.39 in 3Q 2022)Third quarter 2023 results: EPS: ₹1.84 (up from ₹1.39 in 3Q 2022). Revenue: ₹266.4m (up 60% from 3Q 2022). Net income: ₹14.0m (up 32% from 3Q 2022). Profit margin: 5.3% (down from 6.4% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 97% per year, which means it is tracking significantly ahead of earnings growth.
Recent Insider Transactions • Dec 27Chairman & MD recently bought ₹263k worth of stockOn the 22nd of December, Sanjay Goenka bought around 3k shares on-market at roughly ₹87.57 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Sanjay's only on-market trade for the last 12 months.
Reported Earnings • Nov 20Second quarter 2023 earnings released: EPS: ₹0.71 (vs ₹0.97 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.71 (down from ₹0.97 in 2Q 2022). Revenue: ₹190.5m (up 25% from 2Q 2022). Net income: ₹5.41m (down 27% from 2Q 2022). Profit margin: 2.8% (down from 4.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 85% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Oct 13Investor sentiment improved over the past weekAfter last week's 46% share price gain to ₹126, the stock trades at a trailing P/E ratio of 32x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 703% over the past three years.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹76.80, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 391% over the past three years.
Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹87.40, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 462% over the past three years.
Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹73.45, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 372% over the past three years.
Upcoming Dividend • Aug 11Upcoming dividend of ₹0.70 per shareEligible shareholders must have bought the stock before 18 August 2022. Payment date: 25 September 2022. Payout ratio is a comfortable 31% but the company is not cash flow positive. Trailing yield: 2.2%. Within top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (0.7%).
お知らせ • Aug 06Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2022Hindcon Chemicals Limited, Annual General Meeting, Aug 26, 2022, at 13:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₹49.65, the stock trades at a trailing P/E ratio of 12x. Average trailing P/E is 16x in the Chemicals industry in India. Total returns to shareholders of 180% over the past three years.
Reported Earnings • May 31Full year 2022 earnings releasedFull year 2022 results: Revenue: ₹679.9m (up 53% from FY 2021). Net income: ₹42.3m (down 6.4% from FY 2021). Profit margin: 6.2% (down from 10% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Girdhari Goenka was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Mar 11Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹75.50, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 354% over the past three years.
Reported Earnings • Feb 15Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.39 (down from ₹1.61 in 3Q 2021). Revenue: ₹169.9m (up 31% from 3Q 2021). Net income: ₹10.6m (down 14% from 3Q 2021). Profit margin: 6.3% (down from 9.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹70.20, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 305% over the past three years.
Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹70.20, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 305% over the past three years.
Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS ₹0.97 (vs ₹1.48 in 2Q 2021)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹155.8m (up 48% from 2Q 2021). Net income: ₹7.41m (down 34% from 2Q 2021). Profit margin: 4.8% (down from 11% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 20First quarter 2021 earnings released: EPS ₹1.47 (vs ₹0.72 in 1Q 2020)The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: ₹77.0m (down 25% from 1Q 2020). Net income: ₹11.3m (up 104% from 1Q 2020). Profit margin: 15% (up from 5.4% in 1Q 2020). The increase in margin was driven by lower expenses.
Upcoming Dividend • Aug 19Upcoming dividend of ₹2.50 per shareEligible shareholders must have bought the stock before 26 August 2021. Payment date: 13 September 2021. Trailing yield: 2.3%. Within top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.7%).
分析記事 • Aug 14Hindcon Chemicals (NSE:HINDCON) Is Increasing Its Dividend To ₹1.50The board of Hindcon Chemicals Limited ( NSE:HINDCON ) has announced that it will be increasing its dividend on the 4th...
Valuation Update With 7 Day Price Move • Jul 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹41.75, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 105% over the past three years.
Recent Insider Transactions • Jul 02Whole Time Director recently bought ₹743k worth of stockOn the 29th of June, Nilima Goenka bought around 20k shares on-market at roughly ₹37.17 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹2.6m more in shares than they have sold in the last 12 months.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹32.55, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 30% over the past three years.
Valuation Update With 7 Day Price Move • May 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹25.80, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 14% over the past three years.
分析記事 • May 03Is Hindcon Chemicals Limited (NSE:HINDCON) An Attractive Dividend Stock?Is Hindcon Chemicals Limited ( NSE:HINDCON ) a good dividend stock? How can we tell? Dividend paying companies with...
Valuation Update With 7 Day Price Move • Feb 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹20.25, the stock is trading at a trailing P/E ratio of 5.5x, down from the previous P/E ratio of 6.5x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past year are 76%.
分析記事 • Feb 20Estimating The Fair Value Of Hindcon Chemicals Limited (NSE:HINDCON)Does the February share price for Hindcon Chemicals Limited ( NSE:HINDCON ) reflect what it's really worth? Today, we...
Is New 90 Day High Low • Feb 18New 90-day low: ₹24.00The company is down 4.0% from its price of ₹25.00 on 20 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
Recent Insider Transactions • Jan 30MD & Director recently bought ₹100k worth of stockOn the 27th of January, Sanjay Goenka bought around 4k shares on-market at roughly ₹25.08 per share. In the last 3 months, they made an even bigger purchase worth ₹209k. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹2.6m worth in shares.
分析記事 • Jan 16Should Hindcon Chemicals Limited (NSE:HINDCON) Be Part Of Your Dividend Portfolio?Dividend paying stocks like Hindcon Chemicals Limited ( NSE:HINDCON ) tend to be popular with investors, and for good...
Recent Insider Transactions • Jan 16MD & Director recently bought ₹201k worth of stockOn the 13th of January, Sanjay Goenka bought around 8k shares on-market at roughly ₹25.18 per share. In the last 3 months, they made an even bigger purchase worth ₹209k. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹2.5m worth in shares.
Recent Insider Transactions • Jan 06MD & Director recently bought ₹305k worth of stockOn the 29th of December, Sanjay Goenka bought around 12k shares on-market at roughly ₹25.41 per share. This was the largest purchase by an insider in the last 3 months. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹2.6m worth in shares.
分析記事 • Dec 21Whole Time Director Nilima Goenka Just Bought 1.1% More Shares In Hindcon Chemicals Limited (NSE:HINDCON)Whilst it may not be a huge deal, we thought it was good to see that the Hindcon Chemicals Limited ( NSE:HINDCON...
分析記事 • Dec 07Trade Alert: The MD & Director Of Hindcon Chemicals Limited (NSE:HINDCON), Sanjay Goenka, Has Just Spent ₹209k Buying A Few More SharesEven if it's not a huge purchase, we think it was good to see that Sanjay Goenka, the MD & Director of Hindcon...
Recent Insider Transactions • Dec 07MD & Director recently bought ₹209k worth of stockOn the 4th of December, Sanjay Goenka bought around 8k shares on-market at roughly ₹26.18 per share. This was the largest purchase by an insider in the last 3 months. Sanjay has been a buyer over the last 12 months, purchasing a net total of ₹2.1m worth in shares.
分析記事 • Nov 19Read This Before Selling Hindcon Chemicals Limited (NSE:HINDCON) SharesWe often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
Valuation Update With 7 Day Price Move • Nov 18Market bids up stock over the past weekAfter last week's 15% share price gain to ₹22.45, the stock is trading at a trailing P/E ratio of 6.1x, up from the previous P/E ratio of 5.3x. This compares to an average P/E of 16x in the Chemicals industry in India.
Is New 90 Day High Low • Nov 15New 90-day high: ₹19.70The company is up 11% from its price of ₹17.80 on 17 August 2020. The Indian market is also up 11% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 13% over the same period.
Recent Insider Transactions • Oct 03Whole Time Director recently bought ₹660k worth of stockOn the 30th of September, Nilima Goenka bought around 36k shares on-market at roughly ₹18.34 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.4m. Insiders have collectively bought ₹2.5m more in shares than they have sold in the last 12 months.
お知らせ • Jul 17+ 1 more updateHindcon Chemicals Limited to Report First Half, 2020 Results on Jun 25, 2020Hindcon Chemicals Limited announced that they will report first half, 2020 results on Jun 25, 2020
